The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC

OBJECTIVE: Although driver mutation status is crucial to targeted therapy decision-making in non-small cell lung cancer (NSCLC), due to unavailable or inadequate biopsies, there are still many patients with unknown mutation status. A promising way to solve this problem is liquid biopsy, such as cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Shen, Xiaoyan, Li, Rutian, Shen, Jie, Zhang, Hang, Yu, Lixia, Liu, Baorui, Wang, Lifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564806/
https://www.ncbi.nlm.nih.gov/pubmed/28572536
http://dx.doi.org/10.18632/oncotarget.17937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564806/
https://www.ncbi.nlm.nih.gov/pubmed/28572536
http://dx.doi.org/10.18632/oncotarget.17937

Ejemplares similares